• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨泌乳素、运动性闭经与垂体病变并存:诊断陷阱。病例报告。

Concomitant occurrence of macroprolactin, exercise-induced amenorrhea, and a pituitary lesion: a diagnostic pitfall. Case report.

作者信息

Cattaneo F A, Fahie-Wilson M N

机构信息

Department of Endocrinology and Diabetology, University Hospital of Berne, Switzerland.

出版信息

J Neurosurg. 2001 Aug;95(2):334-7. doi: 10.3171/jns.2001.95.2.0334.

DOI:10.3171/jns.2001.95.2.0334
PMID:11780906
Abstract

The authors report the case of a 37-year-old woman who presented with amenorrhea and an increased level of serum prolactin. Magnetic resonance images of the pituitary revealed a lesion with characteristics consistent with those of a microadenoma. Transsphenoidal exploration was performed, but a prolactinoma was not found. After endocrinological review, the patient's hyperprolactinemia was found to be caused by the presence of macroprolactin and her amenorrhea was due to intense exercise and low body weight. Macroprolactin is an isoform of prolactin that is variably reactive in assays for prolactin, but displays minimum bioactivity in vivo. Patients with macroprolactin are mostly asymptomatic. This phenomenon may cause elevated prolactin values, which the authors view as apparent hyperprolactinemia. The presence of macroprolactin is an underrecognized problem, occurring in as many as 15 to 20% of patients with elevated prolactin values and often leading to unnecessary, expensive diagnostic procedures and inappropriate treatment. The presence of macroprolactin should always be suspected when the patient's clinical history or clinical or radiological data are incompatible with the prolactin value. Physicians dealing with diagnosis and treatment of hyperprolactinemia (general practitioners, gynecologists, neurosurgeons, endocrinologists, and biochemists) should be aware of the potentially misleading nature of macroprolactin.

摘要

作者报告了一例37岁女性病例,该患者出现闭经且血清催乳素水平升高。垂体磁共振成像显示有一个病变,其特征与微腺瘤一致。进行了经蝶窦探查,但未发现催乳素瘤。在内分泌学复查后,发现该患者的高催乳素血症是由大分子催乳素的存在引起的,其闭经是由于剧烈运动和体重过低。大分子催乳素是催乳素的一种异构体,在催乳素检测中反应性各异,但在体内显示出最小的生物活性。大分子催乳素患者大多无症状。这种现象可能导致催乳素值升高,作者将其视为明显的高催乳素血症。大分子催乳素的存在是一个未被充分认识的问题,在催乳素值升高的患者中发生率高达15%至20%,常常导致不必要的、昂贵的诊断程序和不恰当的治疗。当患者的临床病史或临床及影像学数据与催乳素值不相符时,应始终怀疑大分子催乳素的存在。处理高催乳素血症诊断和治疗的医生(全科医生、妇科医生、神经外科医生、内分泌学家和生物化学家)应意识到大分子催乳素可能具有误导性。

相似文献

1
Concomitant occurrence of macroprolactin, exercise-induced amenorrhea, and a pituitary lesion: a diagnostic pitfall. Case report.巨泌乳素、运动性闭经与垂体病变并存:诊断陷阱。病例报告。
J Neurosurg. 2001 Aug;95(2):334-7. doi: 10.3171/jns.2001.95.2.0334.
2
Importance of macroprolactinemia in hyperprolactinemia.巨泌乳素血症在高泌乳素血症中的重要性。
Eur J Obstet Gynecol Reprod Biol. 2014 Dec;183:28-32. doi: 10.1016/j.ejogrb.2014.10.013. Epub 2014 Oct 20.
3
Patients with macroprolactinaemia: clinical and radiological features.巨泌乳素血症患者:临床及影像学特征
Eur J Clin Invest. 2007 Jul;37(7):552-7. doi: 10.1111/j.1365-2362.2007.01823.x.
4
The hook effect in prolactin immunoassays.催乳素免疫测定中的钩状效应。
Saudi Med J. 2004 May;25(5):656-9.
5
Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.在开展大分子催乳素筛查之前,高催乳素血症患者常被误诊和误治:一种新的严格的大分子催乳素血症实验室定义的应用
Clin Chem. 2003 Sep;49(9):1504-9. doi: 10.1373/49.9.1504.
6
[Some issues in the diagnosis and treatment of hyperprolactinemia].[高催乳素血症的诊断与治疗中的一些问题]
Zhonghua Fu Chan Ke Za Zhi. 2008 Apr;43(4):241-3.
7
[Macroprolactinemia in the differential diagnosis of hyperprolactinemia].[高催乳素血症鉴别诊断中的巨催乳素血症]
Orv Hetil. 2003 Oct 26;144(43):2121-7.
8
[Prolactin-secreting microadenoma in menopausal women].绝经后女性的泌乳素分泌型微腺瘤
Pan Afr Med J. 2017 Jul 5;27:177. doi: 10.11604/pamj.2017.27.177.11677. eCollection 2017.
9
Macroprolactinemia in patients with prolactinomas: prevalence and clinical significance.催乳素瘤患者中的巨泌乳素血症:患病率及临床意义
Exp Clin Endocrinol Diabetes. 2013 Apr;121(4):201-5. doi: 10.1055/s-0032-1333232. Epub 2013 Apr 17.
10
Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!高催乳素血症并不总是意味着“高催乳素血症”!
Eur J Obstet Gynecol Reprod Biol. 2005 Feb 1;118(2):206-8. doi: 10.1016/j.ejogrb.2004.06.020.

引用本文的文献

1
Gigantomastia and Macroprolactinemia Responding to Cabergoline Treatment: A Case Report and Minireview of the Literature.卡麦角林治疗巨大乳房症和巨泌乳素血症:一例报告及文献综述
Case Rep Endocrinol. 2016;2016:3576024. doi: 10.1155/2016/3576024. Epub 2016 Apr 18.
2
Frequency of Macroprolactinemia in Hyperprolactinemic Women Presenting with Menstrual Irregularities, Galactorrhea, and/or Infertility: Etiology and Clinical Manifestations.高泌乳素血症妇女中伴有月经不规律、溢乳和/或不孕的巨泌乳素血症的频率:病因和临床表现。
Int J Endocrinol. 2013;2013:478282. doi: 10.1155/2013/478282. Epub 2013 Sep 30.
3
The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
测量巨泌乳素在高泌乳素血症患者鉴别诊断中的重要性。
Kaohsiung J Med Sci. 2012 Feb;28(2):94-9. doi: 10.1016/j.kjms.2011.10.030. Epub 2012 Jan 13.
4
Prevalence of pituitary adenomas in macroprolactinemic patients may be higher than it is presumed.在催乳素瘤患者中,垂体腺瘤的患病率可能比人们想象的要高。
Endocrine. 2012 Feb;41(1):138-43. doi: 10.1007/s12020-011-9536-4. Epub 2011 Sep 30.
5
Macroprolactinemia: the consequences of a laboratory pitfall.巨泌乳素血症:实验室检测失误的后果
Endocrine. 2003 Dec;22(3):267-73. doi: 10.1385/ENDO:22:3:267.